Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01417663Phase 3Completed
A Phase 3 trial of alagebrium in arterial stiffness, endothelial dysfunction, sponsored by Radboud University Medical Center. Started Nov 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01417663.